Which is the real nature of glucose‐dependent insulinotropic peptide?: Endogenous vs pharmacological
Saved in:
Main Authors: | Yuji Yamazaki, Yutaka Seino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Journal of Diabetes Investigation |
Online Access: | https://doi.org/10.1111/jdi.14357 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01) -
Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study
by: Maryam Mosavat, et al.
Published: (2020-01-01) -
Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?
by: Dragana Miljic, et al.
Published: (2024-03-01) -
2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
by: Raman Singh, et al.
Published: (2023-01-01) -
Servicesheds connect people to the landscapes upon which they depend
by: Yiyi Zhang, et al.
Published: (2025-01-01)